CLINICAL_TRIALS
trial_result
· 2022-04-13
Clinical Trial Update: PALbociclib CoLlaborative Adjuvant Study [Phase 3]
Summary
Phase 3 trial evaluating palbociclib as adjuvant therapy for breast cancer is not currently recruiting, with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alliance Foundation Trials, LLC. | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-04-13